Adage Capital Partners’s Cabaletta Bio CABA Stock Holding History
Bought
Maintained
Sold
Other funds holding CABA
Adage Capital Partners's CABA Position: Q3 2026 in Review
Adage Capital Partners increased its Cabaletta Bio (CABA) stake by 54% in Q3 2026, buying an estimated $14.1M and bringing the position to 14,174,758 shares worth $27.2M. The position accounts for 0.04% of the portfolio, ranked #409.
Adage Capital Partners first reported a position in CABA in Q4 2019 and has held it in 28 quarters since. The position peaked at $74.2M in Q4 2023. 159 funds tracked by Wall St. Rank hold CABA as of Q3 2026.
- Adage Capital Partners held 14,174,758 shares of Cabaletta Bio worth $27.2M as of Q3 2026.
- Adage Capital Partners bought 5,000,000 Cabaletta Bio shares in Q3 2026, an estimated $14.1M.
- Cabaletta Bio made up 0.04% of Adage Capital Partners's portfolio in Q3 2026, its #409 holding.
- Adage Capital Partners first reported a position in Cabaletta Bio in Q4 2019 and has held it in 28 quarters since.
- Adage Capital Partners's Cabaletta Bio position peaked at $74.2M in Q4 2023.
- 159 funds tracked by Wall St. Rank held Cabaletta Bio as of Q3 2026.
Based on Adage Capital Partners's 13F filing for Q3 2026, filed 16 Nov 2026.